Luminal B/HER2-negative Breast Cancer
1 clinical trials · Condition
◉ Watch Luminal B/HER2-negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER) (NCT05640778) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-10-01 |
Track Luminal B/HER2-negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.